Pneumocystis infection alters the activation state of pulmonary macrophages

Jessica M Deckman1, Cathryn J Kurkjian1, Joseph P McGillis1

  • 1Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street Rm MS409, Lexington, KY 40536, USA.

Immunobiology
|October 11, 2016
PubMed

Insights

Pneumocystis infection reprograms lung macrophages to an alternatively activated state, impacting immune responses. This reprogramming, dependent on IL-4 and IL-13 signaling, may explain declines in lung function.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Microbiology

Background:

  • Pneumocystis jirovecii is frequently found in patients with chronic lung diseases.
  • The effect of Pneumocystis on pulmonary immune regulation is not well understood.

Purpose of the Study:

  • To investigate how Pneumocystis influences macrophage polarization in the lungs.
  • To determine the impact of Pneumocystis-induced macrophage polarization on subsequent immune responses to bacterial infection.

Main Methods:

  • Utilized genetically engineered mice lacking IL-4 and IL-13 signaling pathways.
  • Infected mice with Pneumocystis, followed by challenge with Pseudomonas aeruginosa.
  • Analyzed macrophage phenotype, cytokine production (TGFβ, IL-10), and arginase levels.

Main Results:

  • Pneumocystis induces an alternatively activated macrophage phenotype, dependent on IL-4/IL-13 signaling.
  • Co-infection with Pneumocystis and Pseudomonas aeruginosa resulted in increased alternatively activated macrophages and regulatory cytokine production.
  • Elevated arginase levels were observed in co-infected animals.

Conclusions:

  • Pneumocystis alters the lung macrophage population towards an alternatively activated phenotype.
  • This reprogramming of macrophages by Pneumocystis influences immune responses to secondary infections.
  • Findings may elucidate the link between Pneumocystis infection and reduced lung function.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K